Department of Rheumatology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, United States.
Pediatr Rheumatol Online J. 2021 Aug 13;19(1):120. doi: 10.1186/s12969-021-00604-3.
Juvenile Dermatomyositis (JDM) is an autoimmune disease that typically presents with classic skin rashes and proximal muscle weakness. Anasarca is a rare manifestation of this disease and is associated with a more severe and refractory course, requiring increased immunosuppression. Early recognition of this atypical presentation of JDM may lead to earlier treatment and better outcomes.
We present two female patients, ages 11 years old and 4 years old, who presented to the ED with anasarca and were subsequently diagnosed with JDM. Both patients required ICU-level care and significant immunosuppression, including prolonged courses of IV methylprednisolone, IVIG, and Rituximab.
Anasarca is a rare presentation of Juvenile Dermatomyositis, but it is important for clinicians to recognize this manifestation of the disease. Early recognition and treatment will lead to better outcomes in these children and hopefully decrease the need for prolonged hospitalization and ICU level care.
幼年特发性皮肌炎(JDM)是一种自身免疫性疾病,通常表现为典型的皮疹和四肢近端肌无力。全身性水肿是该病的罕见表现,与更严重和难治性病程相关,需要增加免疫抑制治疗。早期识别 JDM 的这种非典型表现可能会导致更早的治疗和更好的结果。
我们介绍了两名女性患者,年龄分别为 11 岁和 4 岁,因全身性水肿就诊于急诊科,随后被诊断为 JDM。两名患者均需要 ICU 级别的护理和大量免疫抑制治疗,包括长时间的 IV 甲基泼尼松龙、IVIG 和利妥昔单抗治疗。
全身性水肿是幼年特发性皮肌炎的罕见表现,但临床医生识别这种疾病的表现很重要。早期识别和治疗将改善这些儿童的预后,并有望减少长期住院和 ICU 级护理的需求。